The Future of Precision Prevention for Advanced Melanoma
Authors:
Open Access
- 17 January 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8, 818096
Abstract
Precision prevention of advanced melanoma is fast becoming a realistic prospect, with personalized, holistic risk stratification allowing patients to be directed to an appropriate level of surveillance, ranging from skin self-examinations to regular total body photography with sequential digital dermoscopic imaging. This approach aims to address both underdiagnosis (a missed or delayed melanoma diagnosis) and overdiagnosis (the diagnosis and treatment of indolent lesions that would not have caused a problem). Holistic risk stratification considers several types of melanoma risk factors: clinical phenotype, comprehensive imaging-based phenotype, familial and polygenic risks. Artificial intelligence computer-aided diagnostics combines these risk factors to produce a personalized risk score, and can also assist in assessing the digital and molecular markers of individual lesions. However, to ensure uptake and efficient use of AI systems, researchers will need to carefully consider how best to incorporate privacy and standardization requirements, and above all address consumer trust concerns.Keywords
Funding Information
- National Health and Medical Research Council (APP1137127, APP1158111, APP2006551)
- KPMG (RM2018001776)
- Australian Cancer Research Foundation
This publication has 70 references indexed in Scilit:
- Risk Factors for Lentigo Maligna Melanoma Compared With Superficial Spreading MelanomaArchives of Dermatology, 2012
- Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutationsFamilial Cancer, 2011
- A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinomaNature, 2011
- Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UKJournal of Medical Genetics, 2011
- Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry AuditAmerican Journal of Transplantation, 2010
- TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypesJournal of Medical Genetics, 2010
- A Population-Based Study of Australian Twins with Melanoma Suggests a Strong Genetic Contribution to LiabilityJournal of Investigative Dermatology, 2009
- Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factorsEuropean Journal of Cancer, 2005
- MC1R Genotype Modifies Risk of Melanoma in Families Segregating CDKN2A MutationsThe American Journal of Human Genetics, 2001
- Risk of cutaneous melanoma associated with a family history of the diseaseInternational Journal of Cancer, 1995